Hugo Teixeira

Sword is building the future of healthcare through AI Care, a field we pioneered that brings together Artificial Intelligence and Clinical Experts to tackle healthcare’s biggest bottlenecks - access, outcomes, and cost. The result is a world where clinicians are able to focus on what they do best - handling nuance, providing empathy, and delivering the human touch -, while AI focuses on delivering hyper-personalized treatment programs, ensuring scalability, and being available 24/7 so that healthcare meets the needs of the patient, not the other way around. Our platform spans the full continuum of care, from predicting and preventing pain, to treating physical and mental health, and optimizing healthcare operations. We are trusted by over 2,000 organizations globally, across employers, health plans, and governments, having helped our clients generate over $1 billion in healthcare savings, largely by avoiding unnecessary procedures, such as surgeries, imaging, ER visits, and others. We’re backed by some of the world’s most seasoned investors, such as Khosla Ventures, General Catalyst, Founders Fund and others, and currently valued at $4B. We believe in - and are building toward - a world where AI Care is within arm’s reach of every human. If this mission inspires you, join us in building that future: https://swordhealth.com/company/careers.

Streambolico technology provides scalable WiFi video streaming in high density scenarios, by making it possible to deliver video to 10 times more users per WiFi hotspot. Streambolico revolutionizes the video broadcast to any mobile platform using a ubiquitous new delivery channel, WiFi networks. Users can watch their favourite TV channels in the food court, in the airport or in any other public venue using their smart devices, while fans in sport and music events can also view different cameras in their own devices. Streambolico is a spin-off from Instituto de Telecomunicações and from Universidade do Porto and won the grand prize award at the Concurso Nacional de Inovação BES 2012, one of the most prestigious national prizes for awarding innovation.

FLUIDINOVA is a specialized manufacturer of synthetic nanocrystalline hydroxyapatite material, which is commercialized under the brand name nanoXIM. FLUIDINOVA produces highly pure, single phase nano-hydroxyapatite materials, which are supplied worldwide in different forms (pastes and powders) for the manufacture of Medical Devices, Personal Care Product formulations, R&D activities and many other applications. In Oral Care area, our nanohydroxyapatite (nano HA) is used mainly in toothpaste formulations, due to its enamel remineralizing effect and dentine tubule occlusion properties that act as a pain relief agent for sensitive teeth. In medical devices area, over the years nanoXIM is showing its great benefits in bone healing and biocompatibility, being used as an injectable bone substitutes (IBS) for bone regeneration and in bone grafts. Currently nanoXIM is incorporated in FDA approved and CE mark medical devices. nanoXIM Medical Hydroxyapatite nanoparticles for medical device applications such as bone substitutes and grafts aiming bone regeneration. nanoXIM Oral Hydroxyapatite nanoparticles for personal care product formulations, with focus in toothpastes and oral care products. nanoXIM Food Hydroxyapatite nanoparticles for food applications, both to bone fortification and/or to tooth enamel remineralization, effectively reducing dental hypersensitivity. nanoXIM Other Hydroxyapatite nanoparticle pastes and microparticle powders for R&D in many areas, e.g. biotech, bioseparation, biomaterials, drug delivery, pharma and others that need high quality hydroxyapatite.

Biomode | Lighting up pathogen detection 💡 Biomode is an innovative company in the field of rapid pathogen detection in food and clinical samples. The PROBE4® kits developed by Biomode S.A. are based in PNA-FISH technology which combines highly specific fluorescent-labeled probes with fluorescence microscopy enabling a rapid, accurate and color based pathogen identification. The proprietary product series PROBE4® is carefully thought for reliable detection of microorganisms in a wide variety of samples. Safety creates confidence. PROBE4® test kits were designed to fit in your lab’s workflow with the speed you need, with the certainty you need.

Innovative technology Waste Water Heat Recovery #WWHR - High untapped potential immediate energy savings. #architecture #construction Energy savers Zypho reuses thermal energy wasted in the shower to heat cold water. This means lower energy costs and fewer CO2 emissions. WWHR improves #building #energyefficiency by up to 75% - private and public #properties. Solutions that accelerate the shift to a sustainable built environment. https://www.zypho.pt/ #passivhaus certified products *Top 10 technologies to achieve COP26 Goals #europeanunion recommends WWHR solution to improve #buildingenvironment #REPowerEU https://euase.net/short-to-mid-term-measures-in-energy-efficiency-to-reduce-gas-consumption-in-europe/ https://energycoalition.eu/wp-content/uploads/2021/03/220505-CfES-publication-REPowerEU-final.pdf

Sword is building the future of healthcare through AI Care, a field we pioneered that brings together Artificial Intelligence and Clinical Experts to tackle healthcare’s biggest bottlenecks - access, outcomes, and cost. The result is a world where clinicians are able to focus on what they do best - handling nuance, providing empathy, and delivering the human touch -, while AI focuses on delivering hyper-personalized treatment programs, ensuring scalability, and being available 24/7 so that healthcare meets the needs of the patient, not the other way around. Our platform spans the full continuum of care, from predicting and preventing pain, to treating physical and mental health, and optimizing healthcare operations. We are trusted by over 2,000 organizations globally, across employers, health plans, and governments, having helped our clients generate over $1 billion in healthcare savings, largely by avoiding unnecessary procedures, such as surgeries, imaging, ER visits, and others. We’re backed by some of the world’s most seasoned investors, such as Khosla Ventures, General Catalyst, Founders Fund and others, and currently valued at $4B. We believe in - and are building toward - a world where AI Care is within arm’s reach of every human. If this mission inspires you, join us in building that future: https://swordhealth.com/company/careers.

Streambolico technology provides scalable WiFi video streaming in high density scenarios, by making it possible to deliver video to 10 times more users per WiFi hotspot. Streambolico revolutionizes the video broadcast to any mobile platform using a ubiquitous new delivery channel, WiFi networks. Users can watch their favourite TV channels in the food court, in the airport or in any other public venue using their smart devices, while fans in sport and music events can also view different cameras in their own devices. Streambolico is a spin-off from Instituto de Telecomunicações and from Universidade do Porto and won the grand prize award at the Concurso Nacional de Inovação BES 2012, one of the most prestigious national prizes for awarding innovation.

FLUIDINOVA is a specialized manufacturer of synthetic nanocrystalline hydroxyapatite material, which is commercialized under the brand name nanoXIM. FLUIDINOVA produces highly pure, single phase nano-hydroxyapatite materials, which are supplied worldwide in different forms (pastes and powders) for the manufacture of Medical Devices, Personal Care Product formulations, R&D activities and many other applications. In Oral Care area, our nanohydroxyapatite (nano HA) is used mainly in toothpaste formulations, due to its enamel remineralizing effect and dentine tubule occlusion properties that act as a pain relief agent for sensitive teeth. In medical devices area, over the years nanoXIM is showing its great benefits in bone healing and biocompatibility, being used as an injectable bone substitutes (IBS) for bone regeneration and in bone grafts. Currently nanoXIM is incorporated in FDA approved and CE mark medical devices. nanoXIM Medical Hydroxyapatite nanoparticles for medical device applications such as bone substitutes and grafts aiming bone regeneration. nanoXIM Oral Hydroxyapatite nanoparticles for personal care product formulations, with focus in toothpastes and oral care products. nanoXIM Food Hydroxyapatite nanoparticles for food applications, both to bone fortification and/or to tooth enamel remineralization, effectively reducing dental hypersensitivity. nanoXIM Other Hydroxyapatite nanoparticle pastes and microparticle powders for R&D in many areas, e.g. biotech, bioseparation, biomaterials, drug delivery, pharma and others that need high quality hydroxyapatite.

Biomode | Lighting up pathogen detection 💡 Biomode is an innovative company in the field of rapid pathogen detection in food and clinical samples. The PROBE4® kits developed by Biomode S.A. are based in PNA-FISH technology which combines highly specific fluorescent-labeled probes with fluorescence microscopy enabling a rapid, accurate and color based pathogen identification. The proprietary product series PROBE4® is carefully thought for reliable detection of microorganisms in a wide variety of samples. Safety creates confidence. PROBE4® test kits were designed to fit in your lab’s workflow with the speed you need, with the certainty you need.

Innovative technology Waste Water Heat Recovery #WWHR - High untapped potential immediate energy savings. #architecture #construction Energy savers Zypho reuses thermal energy wasted in the shower to heat cold water. This means lower energy costs and fewer CO2 emissions. WWHR improves #building #energyefficiency by up to 75% - private and public #properties. Solutions that accelerate the shift to a sustainable built environment. https://www.zypho.pt/ #passivhaus certified products *Top 10 technologies to achieve COP26 Goals #europeanunion recommends WWHR solution to improve #buildingenvironment #REPowerEU https://euase.net/short-to-mid-term-measures-in-energy-efficiency-to-reduce-gas-consumption-in-europe/ https://energycoalition.eu/wp-content/uploads/2021/03/220505-CfES-publication-REPowerEU-final.pdf